ArticleThe Lancet regional health. Southeast Asia2026
Time to diagnosis of acute kidney injury and its predictors among outborn neonates in India: a competing-risk analysis of tele-ICU network data (2022-2024).
Article in The Lancet regional health. Southeast Asia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There is limited data on neonatal acute kidney injury (AKI) from resource-constrained settings. In this study, we describe time to AKI diagnosis and its predictors among neonates born outside the treating hospital (outborn) in India, accounting for competing events like death and discharge against medical advice (DAMA). Methods: This multicentre retrospective study leveraged data from a tele-NICU network across 27 sites in India from May 2022-June 2024. It included neonates 28 days or younger at admission with two or more serum creatinine values measured within a seven-day span, beginning after 48 h of life. AKI was determined using neonatal modified Kidney Disease: Improving Global Outcomes (KDIGO) criteria. Primary outcome was time-to-AKI diagnosis. Cumulative incidence function was used to estimate AKI risk over time and Cox proportional hazards model was used to identify predictors amid competing events. Secondary outcomes like death, DAMA and length of hospitalisation were described. Findings: Among 570 neonates, sex was recorded for 506; of these, 411 (81.2%) were male and 95 (18.8%) were female. The mean gestational age was 35.4 weeks (SD 3.1; range 24.3-42.7 weeks). Median post-natal age at admission was 2 days (IQR 1-5). AKI occurred in 170 (29.8%) neonates. Median time-to-AKI diagnosis was 2 days (IQR 1-5) post-admission; five-day cumulative incidence was 0.23 (95% CI: 0.20-0.27). Significant predictors of early AKI included dehydration (HR 3.63, 95% CI: 1.67-7.92), mechanical ventilation (HR 1.84, 95% CI: 1.32-2.56) and vasopressor use (HR 1.33, 95% CI: 1.05-1.69). AKI was associated with higher DAMA (34.7% vs. 25.2%, p = 0.02) and Death (13.5% vs. 5.3%, p < 0.01). Interpretation: Outborn neonates have rapid time-to-AKI diagnosis post-admission, highlighting a critical high-risk window for kidney-protective interventions. Policy changes to strengthen medical transport and referral systems may additionally reduce AKI risk among outborn neonates. Funding: Fred Lovejoy Resident Research and Education Award (Boston Children's Hospital).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.